Why GLP-1 agonists have a better safety profile for urinary health The fundamental reason GLP-1 receptor agonists, including tirzepatide, do not cause UTIs comes down to how they lower blood sugar
A recent review highlights curcumins cardioprotective and anti-metabolic syndrome potential, emphasizing that nano-curcumin increases curcumins bioavailability and may enhance therapeutic potency ( 5 Clinical translation of curcumin Multiple phase I and II clinical trials have studied curcumin and its nanoformulations for several cancers, including colorectal, pancreatic, and breast, as well as chronic inflammatory illnesses
This means it primarily targets growth hormone release without significantly impacting other hormones like cortisol or prolactin
2010;154(2):10316 Jang SM, Cerulli J, Grabe DW, Fox C, Vassalotti JA, Prokopienko AJ, Pai AB